Synapse, the fast-growing Birmingham technology start-up that re-engineers spreadsheets to meet the stringent demands placed on financial reporting, announces today that it is in the process of completing a highly successful fundraising round in excess of £1.2 million.
Fertility Focus, the fertility technology experts behind OvuSense, a revolutionary, patented product which doubles the chances of conception each month, has achieved record sales and highest ever revenues during the first quarter of 2018. Of note is the fact that OvuSense is now ...
The new Dashboard, which is available exclusively to members of the Foundrs’ Club, allows participants to monitor and manage all their investments made through Shadow Foundr at the push of a button.
Shadow Foundr is pleased to announce that it has successfully raised - and surpassed - the funding targets for three recent campaigns. LIfT BioSciences, Salad Box and Synapse have all been overfunded through the Shadow Foundr Platform.
With a focus on the fast-growing Education Technology (EdTech) sector, we thought you might be interested to learn that relative newcomer, Shaw Academy (in its sixth year), is currently outperforming 20-year old Lynda.com (bought by LinkedIn in 2015 for $1.5 billion), at the equivalent stage in their development.
Shadow Foundr officially launched its new Foundrs’ Club at a prestigious event in the City of London recently. The club is an exclusive and bespoke service for Shadow Foundr’s network of experienced, discerning, and enthusiastic private investors.Read More
Last year, socially-minded Biotech LIfT BioSciences caught the headlines with the news that it had made an astonishing breakthrough in its research into finding a cure for cancer. The researchers discovered that cancer cells from a well-known human cancer cell-line (HeLa cells), could be killed by ...Read More
Shadow Foundr celebrating as LifT BioSciences hits funding target to develop breakthrough cancer treatment. Alex Blyth, who lost his mother to pancreatic cancer, has successfully raised more than £250,000 to develop a pioneering cancer treatment that shares people’s innate immunity to cancer to help potentially cure cancer patients.Read More
Investing in a start-up can feel like an investment in the future. This is especially true if the start-up is an InsurTech, with the combination of insurance and technology promising innovation and fancy new technologies at the same time.
Shadow Foundr, with good reason, tells its investors that they need to understand a business before making investment decisions. This article’s intention is to help you do the same when considering an investment in InsurTech.
As an investor, you will understand the difficulties sometimes, associated with contacting the start-up or early stage company you’re investing money into. For the investor, there can be miscommunication, it can be hard to maintain voting rights, and there are often no investor protections. Things are equally inconvenient for the business, which must ...Read More